p‐tau217 in a large Peruvian cohort phenotyped for Alzheimer’s Disease
Neetesh Pandey, Lawrence S. Honig, Dolly Reyes‐Dumeyer, Basilio Cieza, Rosa Montesinos, Jennifer Cespedes, Marcio F. Soto‐Añari, Nilton Custodio, Giuseppe Tosto · 2025
Read p‐tau217 in a large Peruvian cohort phenotyped for Alzheimer’s Disease by Neetesh Pandey, Lawrence S. Honig, Dolly Reyes‐Dumeyer, Basilio Cieza, Rosa Montesinos, Jennifer Cespedes, Marcio F. Soto‐Añari, Nilton Custodio, Giuseppe Tosto (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716322.txt.
Description
Neetesh Pandey and co-authors test a blood marker for Alzheimer disease in a Peruvian cohort. Their 2025 study draws 561 samples from mestizo residents of Lima and Indigenous groups in the south of Peru. Most past marker work ran on non-Hispanic White groups, leaving its reach unsure.
The marker, p-tau217, ran far higher in patients with the disease than in healthy peers. It did not split healthy people from those with mild memory loss. Levels rose with each copy of a known risk gene a person carried. The test sorted cases with fair accuracy, well above a past report in a Hispanic group. The authors call it the largest such study in a Hispanic cohort.
Catalog record
| CREATOR | Neetesh Pandey, Lawrence S. Honig, Dolly Reyes‐Dumeyer, Basilio Cieza, Rosa Montesinos, Jennifer Cespedes, Marcio F. Soto‐Añari, Nilton Custodio, Giuseppe Tosto |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |